Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1286studies shown
Showing 1-12 of 1,286
Drug study icon
RecruitingNCT05511363

KarXT for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in France, in the United Kingdom, ...

In France
SchizophreniaDrugA study involving a medication or substance.From 55 Years to 90 Years
Countries
United States, France, United Kingdom, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Drug study icon
RecruitingNCT06887192

ML-007C-MA for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in France, in Canada, ...

In France
SchizophreniaDrugFrom 55 Years to 90 Years
Countries
United States, France, Canada, ...
Sponsor
MapLight Therapeutics
Condition
Schizophrenia
Drug study icon
RecruitingNCT06929273

KarXT for manic episodes in bipolarity type I

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in France, ...

Location not clearly listed
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Australia, France, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Drug study icon
RecruitingNCT06585787

KarXT for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in France, in Belgium, ...

In France
SchizophreniaDrugFrom 55 Years to 90 Years
Countries
United States, France, Belgium, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Drug study icon
RecruitingNCT07140913

KarXT for manic episodes in bipolarity type I

The registry lists this study as recruiting. Study locations are listed in the United States, in France, in Argentina, ...

Location not clearly listed
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, France, Argentina, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Drug study icon
RecruitingNCT07424404

KarXT and KarX-EC for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in France, ...

Location not clearly listed
SchizophreniaDrugFrom 5 Years to 17 Years
Countries
United States, Australia, France, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Drug study icon
RecruitingNCT06159673

ACP-204 in Adults With Alzheimer's Disease Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
SchizophreniaDrugFrom 55 Years to 95 Years
Countries
United States, France, Brazil, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.